Plain language summary of quality of life in CheckMate 9ER: Cabozantinib plus nivolumab in advanced renal cell carcinoma Editorial


Authors: Cella, D.; Motzer, R. J.; Suarez, C.; Blum, S. I.; Ejzykowicz, F.; Hamilton, M.; Wallace, J. F.; Simsek, B.; Zhang, J.; Ivanescu, C.; Choueiri, T. K.; Apolo, A. B.
Title: Plain language summary of quality of life in CheckMate 9ER: Cabozantinib plus nivolumab in advanced renal cell carcinoma
Keywords: metastasis; renal cell carcinoma; kidney; targeted therapy; clinical trials; urologic; cabozantinib
Journal Title: Future Oncology
Volume: 21
Issue: 2
ISSN: 1479-6694
Publisher: Future Medicine  
Date Published: 2025-01-01
Start Page: 181
End Page: 194
Language: English
ACCESSION: WOS:001415626000004
DOI: 10.1080/14796694.2024.2415786
PROVIDER: wos
PMCID: PMC11792805
PUBMED: 39452894
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledge in the PDF -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer